Smart Contact Lenses by 2030: How the Technology Works

More than 140 million people rely on contact lenses worldwide, yet none of those traditional medical devices can beam high-definition images directly onto the human cornea or track systemic glucose levels through tear fluid without drawing blood. Dubai-based deep-tech startup Xpanceo is racing to bridge that exact gap by building an AI-powered smart contact lens ecosystem designed to monitor health parameters and project digital interfaces in real time.

The Wireless Ecosystem Powering Corneal Computing

CNET reported that the company has built 28 working prototypes backed by over 50 patents. Because a lens resting on the eye cannot house its own heavy computing units or power storage safely, the hardware relies on an external companion device worn on the side of the head.

That companion piece houses the primary camera, microphone, and earphone while maintaining a continuous, wireless radio-frequency link to the lens.

“We have built it. It works,” Roman Axelrod told CNET regarding their functional hardware.

Tracking Biomarkers Without Breaking Skin

The eye offers a much more direct window into human physiology via tear fluid, which acts as a filtered proxy for blood chemistry.

“The eye is the next natural frontier of biosensing,” Valentyn Volkov explained to CNET. Tear analysis allows these smart lenses to read electrolytes, proteins, stress hormones, and blood sugar concentrations. The physical curvature of the cornea lets the built-in sensors measure intraocular pressure passively—a vital metric for detecting glaucoma risks early.

Xpanceo Targets 2030 for Broad Consumer Lens Availability

Xpanceo plans to debut its first-generation integrated health-monitoring lens at the Mobile World Congress in Barcelona, which runs from March 1 to 4, 2027. Initial rollouts will target narrow business-to-business contracts, such as specialized lenses for race car drivers who need vehicle metrics projected into their field of view, or medical trials for patients monitoring chronic conditions.

Commercial availability for broader consumer use remains targeted for around 2030, with estimated subscription costs mirroring standard yearly contact lens expenses or baseline smartphone pricing.